Notable Labs, Ltd. NTBLQ
0.00
0.00
NaN
as of 24 Sep
- Market cap
- $2.4M
- P/E
- 0.0×
Follow NTBLQ
Growth Flags
show if company had growth for consecutive years
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | 0.00 | 54.72 | 76.69 | 89.60 | 170.36 | 387.86 | 759.69 |
P/FCF ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | 18.92 | (10.68) | (10.67) | (12.03) | (19.72) | 0.23 | (1.00) |
P/B ratio |
— | 3.53 | 0.60 | 1.20 | 2.67 | 2.59 | 0.00 | 0.40 |
Price to Tangible BV |
— | 3.53 | 0.60 | 1.20 | 2.67 | 2.59 | 0.00 | 0.40 |
EV/Sales |
— | 0.00 | (30.81) | 11.86 | 58.74 | 103.52 | 363.86 | (685.56) |
EV/EBITDA |
— | 0.00 | 0.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.37 |
EV/Operating CF |
— | (37.36) | 1.15 | (0.51) | (2.32) | (3.18) | (0.25) | 0.40 |
EV/FCF |
— | (13.85) | 1.01 | (0.51) | (2.31) | (3.01) | (0.25) | 0.40 |
Quick Ratio |
9.61 | 7.49 | 10.63 | 4.29 | 4.10 | 5.40 | 0.84 | 4.32 |
Current Ratio |
9.73 | 7.72 | 10.83 | 4.36 | 4.29 | 5.53 | 1.48 | 5.65 |
Net Debt/EBITDA |
2.80 | 5.21 | 2.50 | 1.93 | 1.22 | 1.79 | 0.13 | 0.80 |
Debt/Assets |
0.00% | 0.00% | 0.74% | 0.20% | 4.87% | 2.82% | 0.00% | 1.35% |
Debt/Equity |
0.00 | 0.00 | 0.01 | 0.00 | 0.07 | 0.04 | 0.00 | 0.02 |
Asset Turnover |
0.00 | 0.25 | 0.01 | 0.01 | 0.02 | 0.01 | 0.00 | 0.02 |
Operating CF/Net income |
0.84 | 0.38 | 0.77 | 0.67 | 0.97 | 0.84 | 0.81 | 1.22 |
Capex/Depreciation |
(3.78) | (41.55) | (1.92) | (0.06) | (0.04) | (1.17) | 0.17 | (0.25) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (41.35%) | (20.63%) | (37.54%) | (43.53%) | (72.38%) | (73.43%) | (211.68%) | 103.08% | |
| (36.99%) | (17.95%) | (32.38%) | (35.37%) | (53.41%) | (56.26%) | (41.06%) | (89.92%) | |
ROIC |
0.00% | (568.69%) | (433.15%) | 0.00% | (611.83%) | 0.00% | 0.00% | (257.90%) |
Return on Tangible Assets |
(37.68%) | (17.47%) | (36.63%) | (52.58%) | (77.73%) | (57.80%) | (1,017.44%) | (86.33%) |
Average Days of Receivables |
0.00 | 52.65 | 179.07 | 408.51 | 51.07 | 221.00 | 4,653.75 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 128.17% | 2,724.79% | 2,618.15% | 2,131.89% | 2,955.08% | 97,200.00% | 1,518.06% |
Selling, General and Administrative Expense of Revenue |
0.00% | 46.23% | 960.17% | 1,015.66% | 580.80% | 1,003.13% | 64,450.00% | 3,246.45% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 29.95% | 661.03% | 400.53% | 180.15% | 256.25% | 7,262.50% | 190.00% |
Graham Net Nets |
— | 0.25 | 1.38 | 0.58 | 0.26 | 0.31 | (12.73) | 1.82 |
Graham Number |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 136.46 | 0.00 |
Earnings Yield |
— | (5.13%) | (63.85%) | (45.79%) | (29.60%) | (22.82%) | (310.47%) | (185.53%) |
Free Cash Flow Yield |
— | (5.22%) | (55.93%) | (30.54%) | (28.36%) | (20.22%) | (373.46%) | (226.75%) |
Revenue per Share |
0.00 | 17.69 | 0.62 | 0.55 | 0.74 | 0.40 | 0.01 | 0.09 |
Operating CF per Share |
(18.78) | (4.88) | (16.63) | (12.75) | (18.72) | (13.17) | (17.75) | (4.15) |
Capex per Share |
(0.69) | (8.27) | (2.36) | (0.07) | (0.04) | (0.77) | 0.08 | (0.02) |
Free Cash Flow per Share |
(19.47) | (13.15) | (18.99) | (12.83) | (18.76) | (13.94) | (17.66) | (4.17) |
Cash per Share |
63.36 | 69.84 | 53.54 | 35.60 | 24.38 | 28.01 | 2.41 | 3.58 |
Shareholders Equity per Share |
59.37 | 71.34 | 56.31 | 35.10 | 24.76 | 26.66 | (56.35) | 4.58 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
59.37 | 71.34 | 56.31 | 35.10 | 24.76 | 26.66 | (56.35) | 4.58 |
Free Cash Flow |
(13.90) | (10.30) | (17.90) | (13.16) | (23.43) | (26.45) | (11.59) | (13.78) |
Working Capital |
41.79 | 50.89 | 46.94 | 29.11 | 24.53 | 44.92 | 0.97 | 12.73 |
Capital Expenditures |
(0.49) | (6.48) | (2.22) | (0.07) | (0.05) | (1.46) | 0.05 | (0.06) |
Net Current Asset Value |
41.70 | 48.67 | 44.12 | 24.80 | 21.20 | 40.77 | (39.49) | 11.04 |
EV/EBIT |
— | 0.00 | 0.85 | 0.00 | 0.00 | 0.00 | 0.00 | 0.37 |
Capex to Sales |
0.00 | 0.47 | 3.80 | 0.13 | 0.06 | 1.91 | (6.75) | 0.21 |
Net Profit Margin |
0.00% | (73.12%) | (3,497.09%) | (3,451.25%) | (2,627.44%) | (3,895.83%) | (180,087.50%) | (3,633.55%) |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||
Depreciation/Fixed assets |
0.19 | 0.02 | 0.13 | 0.16 | 0.18 | 0.18 | 0.73 | 0.81 |
Cash ROIC |
(16.08%) | (9.90%) | (23.65%) | (28.72%) | (47.34%) | (30.16%) | 34.15% | (51.58%) |
Accounts Receivable Turnover |
0.00 | 10.02 | 0.51 | 1.23 | 2.43 | 2.59 | 0.03 | 0.00 |
Accounts Payable Turnover |
0.03 | 0.06 | 0.04 | 0.04 | 0.06 | 0.05 | 0.02 | 0.15 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
13,443.23 | 7,002.63 | 6,425.55 | 12,340.95 | 5,776.08 | 8,739.00 | 2,853.32 | 3,329.47 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
2.06 | 1.38 | 1.14 | 0.46 | 0.38 | 0.30 | 0.28 | — |
Average Payables |
4.47 | 5.66 | 5.33 | 5.82 | 6.87 | 7.49 | 4.78 | 1.31 |
Average Assets |
43.26 | 56.48 | 63.18 | 54.84 | 45.36 | 53.18 | 35.09 | 12.53 |
Average Common Equity |
38.70 | 49.15 | 54.50 | 44.56 | 33.47 | 40.75 | 6.81 | (10.93) |
Columns are period end dates